4.8 Article

Inhibition Mechanism of Class D β-Lactamases by Avibactam

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Electrostatically induced pK(a) shifts in oligopeptides: the upshot of neighboring side chains

Amir Norouzy et al.

Summary: The pK(a) values of homorepeat hexapeptides with a DBO chromophore attached at the peptide C termini were determined using a fluorescence-based method. The ionization of the side chains resulted in decreased pK(a) values compared to the free amino acid forms. Molecular dynamics simulations revealed that the protonation of side chains led to structural expansion of the peptides.

AMINO ACIDS (2022)

Article Chemistry, Medicinal

Inhibition of the Clostridioides difficile Class D β-Lactamase CDD-1 by Avibactam

Nichole K. Stewart et al.

Summary: Avibactam is a potent irreversible mechanism-based inhibitor of class A and C beta-lactamases, with variable activity against some class D enzymes from Gram-negative bacteria. The interaction of avibactam with recently discovered class D beta-lactamases from Gram-positive bacteria has not been studied. X-ray crystallographic studies demonstrate the rapid formation of a stable CDD-1-avibactam acyl-enzyme complex and differences in anchoring of the inhibitor by class D enzymes from Gram-positive and Gram-negative bacteria.

ACS INFECTIOUS DISEASES (2021)

Article Chemistry, Organic

QM/MM modeling of class A β-lactamases reveals distinct acylation pathways for ampicillin and cefalexin

Zilin Song et al.

Summary: This study utilized efficient computational methods to investigate the acylation reaction catalyzed by CTX-M-44 (Toho-1) beta-lactamase, revealing that the catalytic pathways for beta-lactam hydrolysis are substrate-dependent. The findings offer quantitative insights to aid in the optimization of future beta-lactam antibiotics.

ORGANIC & BIOMOLECULAR CHEMISTRY (2021)

Article Respiratory System

COVID-19 promoting the development of active tuberculosis in a patient with latent tuberculosis infection: A case report

Mohammed Khayat et al.

Summary: A 40-year-old female patient diagnosed with COVID-19 later developed symptoms of pulmonary tuberculosis, suggesting a potential link between COVID-19-induced CD4(+) T-cell depletion and the activation of latent tuberculosis infection. This may have significant implications for the global burden of TB, highlighting the need for early diagnosis and meticulous contact tracing.

RESPIRATORY MEDICINE CASE REPORTS (2021)

Article Chemistry, Medicinal

β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs

Concepcion Gonzalez-Bello et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Multidisciplinary

Elucidating the Molecular Basis of Avibactam-Mediated Inhibition of Class A β-Lactamases

Chandan Kumar Das et al.

CHEMISTRY-A EUROPEAN JOURNAL (2020)

Article Chemistry, Physical

Small Changes in Hydration Determine Cephalosporinase Activity of OXA-48 β-Lactamases

Viivi H. A. Hirvonen et al.

ACS CATALYSIS (2020)

Article Chemistry, Medicinal

IID572: A New Potentially Best-In-Class β-Lactamase Inhibitor

Folkert Reck et al.

ACS INFECTIOUS DISEASES (2019)

Review Biochemistry & Molecular Biology

β-Lactamases and β-Lactamase Inhibitors in the 21st Century

Catherine L. Tooke et al.

JOURNAL OF MOLECULAR BIOLOGY (2019)

Article Chemistry, Multidisciplinary

19F NMR Monitoring of Reversible Protein Post-Translational Modifications: Class D β-Lactamase Carbamylation and Inhibition

Emma van Groesen et al.

CHEMISTRY-A EUROPEAN JOURNAL (2019)

Article Biochemistry & Molecular Biology

Experimental pKa Value Determination of All Ionizable Groups of a Hyperstable Protein

Heiner N. Raum et al.

CHEMBIOCHEM (2019)

Review Infectious Diseases

Pharmacological aspects and spectrum of action of ceftazidime-avibactam: a systematic review

Felipe Francisco Tuon et al.

INFECTION (2018)

Article Microbiology

Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae

Krisztina M. Papp-Wallace et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Chemistry, Physical

Exploring high dimensional free energy landscapes: Temperature accelerated sliced sampling

Shalini Awasthi et al.

JOURNAL OF CHEMICAL PHYSICS (2017)

Article Chemistry, Organic

13C-Carbamylation as a mechanistic probe for the inhibition of class D β-lactamases by avibactam and halide ions

Christopher T. Lohans et al.

ORGANIC & BIOMOLECULAR CHEMISTRY (2017)

Review Infectious Diseases

New agents for the treatment of infections with Gram-negative bacteria: restoring the miracle or false dawn?

H. Wright et al.

CLINICAL MICROBIOLOGY AND INFECTION (2017)

Article Biochemistry & Molecular Biology

Class D β-lactamases do exist in Gram-positive bacteria

Marta Toth et al.

NATURE CHEMICAL BIOLOGY (2016)

Article Chemistry, Medicinal

The road to avibactam: the first clinically useful non-β-lactam working somewhat like a β-lactam

David Yuxin Wang et al.

FUTURE MEDICINAL CHEMISTRY (2016)

Article Chemistry, Physical

Deacylation Mechanism and Kinetics of Acyl Enzyme Complex of Class C β-Lactamase and Cephalothin

Ravi Tripathi et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2016)

Article Chemistry, Physical

Mechanism of Meropenem Hydrolysis by New Delhi Metallo β-Lactamase

Ravi Tripathi et al.

ACS CATALYSIS (2015)

Article Chemistry, Medicinal

Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition

Dustin T. King et al.

ACS INFECTIOUS DISEASES (2015)

Review Microbiology

OXA β-Lactamases

Benjamin A. Evans et al.

CLINICAL MICROBIOLOGY REVIEWS (2014)

Review Chemistry, Multidisciplinary

Class D β-Lactamases: A Reappraisal after Five Decades

David A. Leonard et al.

ACCOUNTS OF CHEMICAL RESEARCH (2013)

Review Pharmacology & Pharmacy

Ceftazidime-Avibactam: a Novel Cephalosporin/beta-lactamase Inhibitor Combination

George G. Zhanel et al.

DRUGS (2013)

Article Biochemistry & Molecular Biology

Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases

David E. Ehmann et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Chemistry, Multidisciplinary

Mechanism of Acyl-Enzyme Complex Formation from the Henry-Michaelis Complex of Class C β-Lactamases with β-Lactam Antibiotics

Ravi Tripathi et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)

Review Infectious Diseases

OXA-48-like carbapenemases: the phantom menace

Laurent Poirel et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

Article Multidisciplinary Sciences

Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor

David E. Ehmann et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Microbiology

Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors

Ken Coleman

CURRENT OPINION IN MICROBIOLOGY (2011)

Article Multidisciplinary Sciences

Large shifts in pKa values of lysine residues buried inside a protein

Daniel G. Isom et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Microbiology

Three Decades of beta-Lactamase Inhibitors

Sarah M. Drawz et al.

CLINICAL MICROBIOLOGY REVIEWS (2010)

Article Pharmacology & Pharmacy

Current Challenges in Antimicrobial Chemotherapy Focus on beta-Lactamase Inhibition

Carine Bebrone et al.

DRUGS (2010)

Article Infectious Diseases

Emerging carbapenemases: a global perspective

Timothy R. Walsh

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)

Article Multidisciplinary Sciences

Charges in the hydrophobic interior of proteins

Daniel G. Isom et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Biochemistry & Molecular Biology

Protein Ionizable Groups: pK Values and Their Contribution to Protein Stability and Solubility

C. Nick Pace et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Physics, Multidisciplinary

Well-tempered metadynamics: A smoothly converging and tunable free-energy method

Alessandro Barducci et al.

PHYSICAL REVIEW LETTERS (2008)

Article Biochemistry & Molecular Biology

pK values of the ionizable groups of proteins

RL Thurlkill et al.

PROTEIN SCIENCE (2006)

Review Infectious Diseases

OXA-type carbapenemases

J Walther-Rasmussen et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)

Review Biochemistry & Molecular Biology

Resistance to β-lactam antibiotics

K Poole

CELLULAR AND MOLECULAR LIFE SCIENCES (2004)

Article Chemistry, Multidisciplinary

Development and testing of a general amber force field

JM Wang et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)

Article Chemistry, Physical

Theoretical study of the alkaline hydrolysis of an aza-β-lactam derivative of clavulanic acid

RC Garcías et al.

CHEMICAL PHYSICS LETTERS (2003)

Article Multidisciplinary Sciences

Escaping free-energy minima

A Laio et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Chemistry, Multidisciplinary

High-resolution X-ray structure of an acyl-enzyme species for the class D OXA-10 β-lactamase

L Maveyraud et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)

Review Biochemistry & Molecular Biology

Structural basis of perturbed pKa values of catalytic groups in enzyme active sites

TK Harris et al.

IUBMB LIFE (2002)

Article Multidisciplinary Sciences

Critical involvement of a carbamylated lysine in catalytic function of class D β-lactamases

D Golemi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Chemistry, Physical

Theoretical study of the alkaline hydrolysis of a bicyclic aza-β-lactam

M Coll et al.

JOURNAL OF PHYSICAL CHEMISTRY B (2000)